Home > Insider Trading > Filing (0001104659-18-048808)

Filing Details

Accession Number:: 0001104659-18-048808
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-08-01 17:13:19
Reporting Period:: 2018-07-30

Accepted Time:: 2018-08-01 17:13:19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1330436	Liquidia Technologies Inc	LQDA	Surgical & Medical Instruments & Apparatus (3841)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1400308	M Stephen Bloch	C/O Canaan Partners 285 Riverside Avenue, Suite 250 Westport CT 06880		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-07-30	87,837	$0.00	90,536	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2018-07-30	89,630	$0.00	180,166	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2018-07-30	31,471	$0.00	211,637	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2018-07-30	680,266	$0.00	891,903	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2018-07-30	944,127	$0.00	1,836,030	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2018-07-30	727,273	$11.00	2,563,303	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2018-07-30	918,657	$0.00	87,837	$0.00
Common Stock	Series A-1 Preferred Stock	Disposition	2018-07-30	650,427	$0.00	89,630	$0.00
Common Stock	Series B Preferred Stock	Disposition	2018-07-30	222,529	$0.00	31,471	$0.00
Common Stock	Series C Preferred Stock	Disposition	2018-07-30	5,254,658	$0.00	680,266	$0.00
Common Stock	Series D Preferred Stock	Disposition	2018-07-30	15,887,155	$0.00	944,127	$0.00
Series D Preferred Stock	Warrant to purchase Series D Preferred Stock	Disposition	2018-07-30	578,498	$0.00	578,498	$0.01
Common Stock	Warrant to purchase Common Stock	Acquisiton	2018-07-30	34,378	$0.00	34,378	$0.01

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	C	Indirect
0			No	4	C	Indirect
0			No	4	C	Indirect
0			No	4	C	Indirect
0	2017-01-09	2026-12-31	No	4	J	Indirect
34,378	2017-01-09	2026-12-31	No	4	J	Indirect

Footnotes

The Series A preferred stock had no expiration date and automatically converted into the Issuer's common stock on a 0.0956-for-1 basis immediately prior to the closing of the Issuer's initial public offering.
The Series A-1 preferred stock had no expiration date and automatically converted into the Issuer's common stock on a 0.1378-for-1 basis immediately prior to the closing of the Issuer's initial public offering.
The Series B preferred stock had no expiration date and automatically converted into the Issuer's common stock on a 0.1414-for-1 basis immediately prior to the closing of the Issuer's initial public offering.
The Series C preferred stock had no expiration date and automatically converted into the Issuer's common stock on a 0.1295-for-1 basis immediately prior to the closing of the Issuer's initial public offering.
The Series D preferred stock had no expiration date and automatically converted into the Issuer's common stock on a 0.0594-for-1 basis immediately prior to the closing of the Issuer's initial public offering.
Immediately prior to the closing of the Issuer's initial public offering and without payment of further consideration, the Warrant to purchase Series D Preferred Stock automatically became exercisable to purchase the Issuer's common stock. The transaction is listed solely for the purpose of reporting the change of the title and amount of securities underlying the warrant.
The securities are held directly by Canaan VIII L.P. ("Canaan LP"). Canaan Partners VIII LLC ("Canaan LLC" and together with Canaan LP, the "Canaan Entities") is the sole general partner of Canaan LP. Investment and voting decisions with respect to the securities held by Canaan LP are made by the managers of Canaan LLC, collectively. Dr. Bloch disclaims beneficial ownership in the securities held by the Canaan Entities, except to the extent of his pecuniary interest, if any, in such securities by virtue of the limited liability company interests he owns in Canaan LLC.